Keyphrases
Myocardial Infarction
100%
Heparin
100%
Angiographic Findings
100%
Tissue Plasminogen Activator (t-PA)
100%
Placebo
57%
Perfusion
28%
Infarct
28%
Lumen Area
28%
Placebo-controlled Trial
14%
Infarction
14%
Coronary Artery
14%
Rapid Improvement
14%
Anatomic Characteristics
14%
Recombinant Tissue Plasminogen Activator (rt-PA)
14%
Infarct-related Coronary Artery
14%
Spontaneous Recanalization
14%
Hospital Course
14%
Acute Myocarditis
14%
Patency
14%
Quantitative Coronary Angiography
14%
Coronary Angiography
14%
Thrombolysis in Myocardial Infarction Risk Score
14%
Placebo Groups
14%
Thrombolytic Agents
14%
Medicine and Dentistry
Myocardial Infarction
100%
Heparin
100%
Tissue Plasminogen Activator
100%
Placebo
100%
Infarction
66%
Coronary Artery
33%
Blood Clot Lysis
16%
Venous Ulcer
16%
Recanalization
16%
Quantitative Coronary Angiography
16%
Coronary Angiography
16%
Thrombolytic Drug
16%
Alteplase
16%
Nursing and Health Professions
Heart Infarction
100%
Placebo
100%
Tissue Plasminogen Activator
100%
Heparin
100%
Infarction
66%
Perfusion
33%
Coronary Angiography
33%
Ulcer Index
16%
Fibrinolytic Agent
16%
Recanalization
16%
Alteplase
16%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Heart Infarction
100%
Tissue Plasminogen Activator
100%
Heparin
100%
Infarction
66%
Ulcer
16%
Fibrinolytic Agent
16%
Alteplase
16%